Institutional Ownership Vera Therapeutics, Inc. (VERA)
This table provides information about the institutional ownership of Vera Therapeutics, Inc. (VERA). We have compiled data on the 172 institutions that hold shares in the stock, with a total of 52.6 Million shares, which have been reported (via 13F filing form) to have a value of $2.18 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Avoro Capital Advisors LLC
New York, NY |
May 15, 2024 Q1 2024 |
5,265,000
shares
|
$218 Million
2.74% of portfolio
|
Q1 2024
New holding
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
3,318,964
shares
|
$137 Million
0.0% of portfolio
|
Q1 2024
Added 20.48%
|
|
Commodore Capital LP
New York, NY |
May 15, 2024 Q1 2024 |
3,165,000
shares
|
$131 Million
11.79% of portfolio
|
Q1 2024
Reduced 41.93%
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
2,960,231
shares
|
$123 Million
19.0% of portfolio
|
Q2 2021
New holding
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
May 15, 2024 Q1 2024 |
2,793,987
shares
|
$116 Million
7.01% of portfolio
|
Q1 2024
Reduced 19.42%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 15, 2024 Q1 2024 |
2,393,029
shares
|
$99 Million
0.01% of portfolio
|
Q1 2024
New holding
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
2,350,727
shares
|
$97.3 Million
0.0% of portfolio
|
Q1 2024
Added 7.78%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
2,148,714
shares
|
$88.9 Million
0.0% of portfolio
|
Q1 2024
Added 31.53%
|
|
Eversept Partners, LP
New York, NY |
May 15, 2024 Q1 2024 |
1,823,781
shares
|
$75.5 Million
5.9% of portfolio
|
Q1 2024
Reduced 4.75%
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
1,536,790
shares
|
$63.6 Million
0.01% of portfolio
|
Q1 2024
Added 54.48%
|
|
Kynam Capital Management, LP
Princeton, NJ |
May 15, 2024 Q1 2024 |
1,526,787
shares
|
$63.2 Million
6.91% of portfolio
|
Q1 2024
Reduced 58.17%
|
|
Holocene Advisors, LP
New York, NY |
May 15, 2024 Q1 2024 |
1,207,380
shares
|
$50 Million
0.2% of portfolio
|
Q1 2024
New holding
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
May 15, 2024 Q1 2024 |
1,175,148
shares
|
$48.6 Million
0.13% of portfolio
|
Q1 2024
Added 19.39%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 14, 2024 Q1 2024 |
1,011,550
shares
|
$41.9 Million
0.05% of portfolio
|
Q1 2024
Reduced 23.86%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
961,309
shares
|
$39.8 Million
0.0% of portfolio
|
Q1 2024
Added 22.82%
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2024 Q1 2024 |
947,097
shares
|
$39.2 Million
0.39% of portfolio
|
Q1 2024
Reduced 62.22%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
919,352
shares
|
$38.1 Million
0.02% of portfolio
|
Q2 2023
New holding
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2024 Q1 2024 |
837,195
shares
|
$34.7 Million
0.07% of portfolio
|
Q1 2024
New holding
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
758,355
shares
|
$31.4 Million
3.53% of portfolio
|
Q3 2023
Reduced 22.24%
|
|
Altium Capital Management LP
New York, NY |
May 15, 2024 Q1 2024 |
710,000
shares
|
$29.4 Million
17.25% of portfolio
|
Q1 2024
Added 15.45%
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2024 Q1 2024 |
675,872
shares
|
$28 Million
0.66% of portfolio
|
Q1 2024
Reduced 55.48%
|
|
Polar Capital Holdings PLC
London, X0 |
May 15, 2024 Q1 2024 |
675,000
shares
|
$27.9 Million
0.18% of portfolio
|
Q1 2024
Reduced 6.9%
|
|
Samlyn Capital, LLC
New York, NY |
May 15, 2024 Q1 2024 |
645,501
shares
|
$26.7 Million
0.49% of portfolio
|
Q1 2024
New holding
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 15, 2024 Q1 2024 |
636,994
shares
|
$26.4 Million
0.01% of portfolio
|
Q1 2024
Added 0.52%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2024 Q1 2024 |
601,036
shares
|
$24.9 Million
0.02% of portfolio
|
Q1 2024
Added 186.15%
|